Emerging Infectious Diseases (Jan 2024)
Emergence of Novel Norovirus GII.4 Variant
- Preeti Chhabra,
- Damien C. Tully,
- Janet Mans,
- Sandra Niendorf,
- Leslie Barclay,
- Jennifer L. Cannon,
- Anna M. Montmayeur,
- Chao-Yang Pan,
- Nicola Page,
- Rachel Williams,
- Helena Tutill,
- Sunando Roy,
- Cristina Celma,
- Stuart Beard,
- Michael L. Mallory,
- Gédéon Prince Manouana,
- Thirumalaisamy P. Velavan,
- Ayola Akim Adegnika,
- Peter G. Kremsner,
- Lisa C. Lindesmith,
- Stéphane Hué,
- Ralph S. Baric,
- Judith Breuer,
- Jan Vinjé
Affiliations
- Preeti Chhabra
- Damien C. Tully
- Janet Mans
- Sandra Niendorf
- Leslie Barclay
- Jennifer L. Cannon
- Anna M. Montmayeur
- Chao-Yang Pan
- Nicola Page
- Rachel Williams
- Helena Tutill
- Sunando Roy
- Cristina Celma
- Stuart Beard
- Michael L. Mallory
- Gédéon Prince Manouana
- Thirumalaisamy P. Velavan
- Ayola Akim Adegnika
- Peter G. Kremsner
- Lisa C. Lindesmith
- Stéphane Hué
- Ralph S. Baric
- Judith Breuer
- Jan Vinjé
- DOI
- https://doi.org/10.3201/eid3001.231003
- Journal volume & issue
-
Vol. 30,
no. 1
pp. 163 – 167
Abstract
We detected a novel GII.4 variant with an amino acid insertion at the start of epitope A in viral protein 1 of noroviruses from the United States, Gabon, South Africa, and the United Kingdom collected during 2017–2022. Early identification of GII.4 variants is crucial for assessing pandemic potential and informing vaccine development.
Keywords
